163 related articles for article (PubMed ID: 26684748)
1. Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barré Syndrome.
Wang Y; Li G; Yang S; Gu X; Li X; Liu M; Wu X; Guan Y; Press R; Zhu J; Zhang HL
PLoS One; 2015; 10(12):e0145075. PubMed ID: 26684748
[TBL] [Abstract][Full Text] [Related]
2. Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barré syndrome.
Gong Q; Liu S; Xiao Z; Fu X; Lu Z
Neurol Res; 2022 Feb; 44(2):121-127. PubMed ID: 34382919
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barré syndrome: a retrospective study.
Wang Y; Shang P; Xin M; Bai J; Zhou C; Zhang HL
BMC Neurol; 2017 Nov; 17(1):200. PubMed ID: 29157205
[TBL] [Abstract][Full Text] [Related]
4. More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barré syndrome in Northeast China.
Wu X; Wu W; Wang Z; Shen D; Pan W; Wang Y; Wu L; Wu X; Feng J; Liu K; Zhu J; Zhang HL
PLoS One; 2014; 9(8):e104074. PubMed ID: 25084153
[TBL] [Abstract][Full Text] [Related]
5. Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression.
Gao Y; Zhang HL; Xin M; Wang D; Zheng N; Wang S; Xu J; Wang Y; Zhu J; Feng J
Biomed Res Int; 2018; 2018():5703279. PubMed ID: 30013984
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome.
Wen P; Wang L; Liu H; Gong L; Ji H; Wu H; Chu W
Sci Rep; 2021 Jun; 11(1):11578. PubMed ID: 34079013
[TBL] [Abstract][Full Text] [Related]
7. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
Verma R; Chaudhari TS; Raut TP; Garg RK
J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
[TBL] [Abstract][Full Text] [Related]
8. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barré syndrome.
Wu X; Li C; Zhang B; Shen D; Li T; Liu K; Zhang HL
Crit Care; 2015 Sep; 19(1):310. PubMed ID: 26330143
[TBL] [Abstract][Full Text] [Related]
9. Hyponatremia is a predictor for poor outcome in Guillain-Barré syndrome.
Wang Y; Liu J
Neurol Res; 2015 Apr; 37(4):347-51. PubMed ID: 25366666
[TBL] [Abstract][Full Text] [Related]
10. The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.
Kong L; Wu X; Cheng Y; Liu S; Liu K; Li C
Neurol Sci; 2022 Aug; 43(8):5017-5028. PubMed ID: 35469074
[TBL] [Abstract][Full Text] [Related]
11. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
[TBL] [Abstract][Full Text] [Related]
12. Hyponatraemia in Guillain-Barré syndrome revisited.
Hiew FL; Winer JB; Rajabally YA
Acta Neurol Scand; 2016 Apr; 133(4):295-301. PubMed ID: 26184092
[TBL] [Abstract][Full Text] [Related]
13. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
14. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
15. The clinical characteristics and short-term prognosis in elderly patients with Guillain-Barré syndrome.
Zhang B; Wu X; Shen D; Li T; Li C; Mao M; Zhang HL; Liu K
Medicine (Baltimore); 2017 Jan; 96(1):e5848. PubMed ID: 28072747
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation.
Netto AB; Taly AB; Kulkarni GB; Uma Maheshwara Rao GS; Rao S
Neurol India; 2011; 59(5):707-11. PubMed ID: 22019655
[TBL] [Abstract][Full Text] [Related]
17. Predictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study.
Khedr EM; Mahmoud DM; Ahmed GK; Haridy NA
Clin Neurol Neurosurg; 2023 Dec; 235():108026. PubMed ID: 37913589
[TBL] [Abstract][Full Text] [Related]
18. Is serum bilirubin associated with the severity of Guillain-Barré syndrome?
Li X; Li W; Shi X; Mo L; Luo Y; Qin L; Yang Z; Mo W
Int J Neurosci; 2018 Jul; 128(7):595-599. PubMed ID: 29130362
[TBL] [Abstract][Full Text] [Related]
19. HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.
Geleijns K; Schreuder GM; Jacobs BC; Sintnicolaas K; van Koningsveld R; Meulstee J; Laman JD; van Doorn PA
Neurology; 2005 Jan; 64(1):44-9. PubMed ID: 15642902
[TBL] [Abstract][Full Text] [Related]
20. Early predictors of functional disability in Guillain-Barré Syndrome.
Tunç A
Acta Neurol Belg; 2019 Dec; 119(4):555-559. PubMed ID: 30963477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
